Between the high cost and testing hurdles, molnupiravir may not be the “game changer” against COVID. Read More
Related Articles
What Wall Street’s Treasured election Signs say about who’ll win the White House at 2020
Posted on Author admin
It is a time-honored convention on Wall Street each four decades: proclamations from analysts and observers who assert that this or economic metric could correctly predict who is going to be the next President of the USA. After the identity of those that will inhabit the White House is really a significant, market-moving factor –one […]
Inflation is rising, but yields are sinking—and that bodes well for stocks
Posted on Author admin
U.S. futures are gaining, following Europe higher. Read More
Corporate America, we need to talk about activism
Posted on Author admin
Here’s the honest truth, we need to talk about a lot of things. Matthew McCarthy, Ben & Jerry’s CEO, has a message for CEOs who are worried about walking the talk: Don’t let fear hold you back. But first, here’s your Bob Marley- inspired week in review, in Haiku. Don’t worry, ‘bout athing, cause every […]